PlainRecalls
FDA Devices Moderate Class II Ongoing

Vanta with AdaptiveStim Implantable Neurostimulator, Model 977006; spinal chord stimulation

Reported: July 5, 2023 Initiated: June 6, 2023 #Z-2036-2023

Product Description

Vanta with AdaptiveStim Implantable Neurostimulator, Model 977006; spinal chord stimulation

Reason for Recall

A cardioversion procedure may damage the electronics in the Vanta INS device, making the INS unresponsive and non-functional. As of April 19, 2023, Medtronic has received a total of two complaints concerning this issue from patients implanted with a Vanta INS, both of which have resulted in explant procedures.

Details

Recalling Firm
Medtronic Neuromodulation
Units Affected
3791 devices
Distribution
Worldwide distribution.
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Vanta with AdaptiveStim Implantable Neurostimulator, Model 977006; spinal chord stimulation. Recalled by Medtronic Neuromodulation. Units affected: 3791 devices.
Why was this product recalled?
A cardioversion procedure may damage the electronics in the Vanta INS device, making the INS unresponsive and non-functional. As of April 19, 2023, Medtronic has received a total of two complaints concerning this issue from patients implanted with a Vanta INS, both of which have resulted in explant procedures.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 5, 2023. Severity: Moderate. Recall number: Z-2036-2023.